Table 2

Differences in the cardiometabolic risk factors between adults who adhere or did not adhere to the recommended physical activity

Risk factorsNon-adherenceAdherenceBeta coefficient (95% CI)P value
Waist (cm)105.0 (104.1 to 105.9)102.8 (102.0 to 103.7)−2.201 (−3.225 to −1.178)<0.001
BMI30.5 (30.0 to 31.0)28.9 (28.6 to 29.3)−0.052 (−0.072 to −0.032)<0.001
Systolic BP (mm Hg)125.1 (123.9 to 126.3)125.4 (124.2 to 126.5)0.281 (−1.217 to 1.779)0.710
Diastolic BP (mm Hg)70.1 (69.0 to 71.1)70.5 (69.7 to 71.4)0.477 (−0.912 to 1.866)0.496
HDL-C (mg/dL)50.6 (49.6 to 51.6)52.5 (51.5 to 53.5)0.037 (0.012 to 0.062)0.005
Triglycerides (mg/dL)117.3 (112.5 to 122.3)111.2 (108.0 to 114.5)−0.054 (−0.101 to −0.006)0.027
Insulin (μU/mL)14.1 (13.4 to 14.7)12.5 (12.0 to 13.0)−0.117 (−0.167 to −0.066)<0.001
2-hour glucose (mg/dL)124.3 (121.2 to 127.4)119.0 (116.3 to 121.8)−0.042 (−0.079 to −0.007)0.021
HOMA-IR3.7 (3.5 to 3.9)3.3 (3.1 to 3.4)−0.119 (−0.172 to −0.066)<0.001
HOMA-β118.8 (113.7 to 124.2)106.4 (102.7 to 110.3)−0.110 (−0.158 to −0.062)<0.001
HbA1c5.62 (5.59 to 5.65)5.61 (5.59 to 5.63)−0.008 (−0.043 to 0.027)0.657
  • Data are presented as mean with 95% CIs in parentheses.

  • The P values with statistic significance were boldfaced.

  • .BMI, body mass index; BP, blood pressure; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, Homeostatic Model Assessment for Insulin Resistance; HOMA-β, homeostasis model assessment of β-cell function.